APA (7th ed.) Citation

Xun, J., Ohtsuka, H., Hirose, K., Douchi, D., Nakayama, S., Ishida, M., . . . Unno, M. (2023). Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11294-3

Chicago Style (17th ed.) Citation

Xun, Jingyu, et al. "Reduced Expression of Phosphorylated Ataxia-telangiectasia Mutated Gene Is Related to Poor Prognosis and Gemcitabine Chemoresistance in Pancreatic Cancer." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11294-3.

MLA (9th ed.) Citation

Xun, Jingyu, et al. "Reduced Expression of Phosphorylated Ataxia-telangiectasia Mutated Gene Is Related to Poor Prognosis and Gemcitabine Chemoresistance in Pancreatic Cancer." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11294-3.